Whoever did that may think that the Australia do not do the same kick-backs for Orphan drugs as the US.
Australia follow the US processes to be able to sell in to the biggest market in the world. Australia offers the same benefits for orphan drug development as the US, with the condition of a passing a 'cost effective analysis' set out by Pharmaceutical Benefits Advisory Committee Australia.
We know the finished product (ALT1103) will undercut Somavert by 50% so I can not see ANP failing the CEA test.
DYOR and look closer guys we are on a good thing here!
- Forums
- ASX - By Stock
- PER
- atl1103 anti cancer medications
atl1103 anti cancer medications, page-41
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 8.0¢ | $29.39K | 366.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6275 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 242816 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6275 | 0.080 |
1 | 42922 | 0.079 |
2 | 30620 | 0.078 |
1 | 10000 | 0.077 |
1 | 26000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 242816 | 1 |
0.083 | 100000 | 1 |
0.084 | 100250 | 1 |
0.085 | 100000 | 1 |
0.086 | 291111 | 3 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online